WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and refer. ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Agilon and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognize ...

Summary of Agilon Health Conference Call Company Overview - Agilon Health is a value-based care company focused on primary care, operating in multiple states with partnerships with primary care physicians [6][7] - The company has entered into 20-year partnerships with around 2,200 primary care physicians across 12 states and 30 markets [6] Core Business Model - Agilon Health operates under capitated arrangements with payers, taking a percentage of premiums and being responsible for total healthcare costs for its members [7] - The company serves approximately 117,000 members in the ACO REACH program, achieving gross savings of $150 million in 2023, with cost trends 300 basis points below the Medicare benchmark [7][8] Performance Metrics - The company reports a 20% to 30% reduction in hospital admissions per thousand, lower emergency room admissions, and higher quality ratings (star scores greater than 4) [8] - The enhanced data pipeline launched in Q1 is expected to significantly improve operational efficiency and cost visibility [8][14] Strategic Focus and Challenges - In 2024, Agilon Health doubled its size but faced challenges due to flat macro cost trends and rates, leading to a narrowed focus on profitability for 2025 [12][13] - The company has intentionally slowed growth to prioritize profitability, with a focus on ensuring adequate compensation for risks taken [12][13] Part D Risk Management - The company has reduced its exposure to Part D risk from 66% in 2024 to less than 30% in 2025, with expectations to lower it further in 2026 [13][23] - The removal of Part D risk is a strategic priority due to its volatility and financial impact [22][23] Data Pipeline and Cost Visibility - The new data pipeline allows for member-level revenue and cost detail, enhancing the company's ability to predict medical costs and risk scores [19][20] - Approximately 72% of members were integrated into the data pipeline by the end of Q2, with ongoing efforts to expand this [17] ACO REACH Program Success - Agilon Health is one of the largest participants in the ACO REACH program, delivering superior savings and quality results through its partnership model [34][35] - The program's structure reduces variability and enhances performance compared to Medicare Advantage [34] Future Outlook - The company anticipates a more favorable macro backdrop for 2026, with expectations of improved profitability driven by better rates and cost control measures [41][52] - Agilon Health is focused on clinical programs and risk adjustment strategies to enhance financial performance [48][49] Key Takeaways for Investors - Agilon Health operates in a long-cycle business, with financial improvements expected to materialize over time [49] - The company is positioned for meaningful profitability growth from 2025 to 2026, with a focus on quality performance and cost management [52]

Core Insights - Agilon Health, Inc. has significantly reduced its 2023 profit forecasts, particularly lowering its Medical Margin expectation to between $340 million and $360 million, which is approximately $110 million below previous guidance due to $90 million in unexpected medical costs [2] - The company and certain executives are facing a securities class action lawsuit for allegedly failing to disclose material information during the Class Period, violating federal securities laws, with the court recently denying the company's motion to dismiss the case [3] - Kahn Swick & Foti, LLC is conducting an investigation into whether agilon's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws [3] Company Background - Kahn Swick & Foti, LLC is a prominent boutique securities litigation law firm, ranked among the top 10 firms nationally based on total settlement value, serving both institutional and retail investors seeking recoveries for investment losses due to corporate fraud or malfeasance [4]

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 2025 Jefferies Healthcare Services Conference on Tuesday, September 30 at 8:45am ET. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the "Events & Presentations†section of agilon health's invest. ...

Core Viewpoint - Kahn Swick & Foti, LLC is investigating agilon health, inc. following a significant reduction in its 2023 profit forecasts and subsequent legal actions against the company and its executives for failing to disclose material information [1][2]. Group 1: Company Financials - Agilon health, inc. has lowered its 2023 Medical Margin expectation to a range of $340 million to $360 million, which is approximately $110 million below previous guidance due to $90 million in higher-than-expected medical costs [1]. - The company's Chief Financial Officer, Timothy Bensley, is set to retire later in the year [1]. Group 2: Legal Proceedings - A securities class action lawsuit has been filed against agilon and certain executives, alleging violations of federal securities laws by failing to disclose material information during the Class Period [2]. - The court has denied the company's motion to dismiss the case, allowing the lawsuit to proceed [2]. - KSF's investigation is focused on whether agilon's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws [2]. Group 3: Kahn Swick & Foti, LLC Overview - Kahn Swick & Foti, LLC is recognized as one of the top boutique securities litigation law firms in the U.S., with a focus on recovering investment losses due to corporate fraud [3]. - The firm has been ranked among the top 10 nationally based on total settlement value [3]. - KSF serves a diverse clientele, including public and private institutional investors, as well as retail investors [3].

Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...

Financial Data and Key Metrics Changes - Revenue for FY 2025 was $165.2 million, down 22% from the prior year [17] - Net loss after tax was €2.9 million, an improvement from a €10 million loss in the previous year [17] - Operating expenses were reduced by £6 million through property consolidation and resizing support teams [17][18] - No dividend was declared for the year ending March 31, 2025, reflecting a prudent approach due to uncertain economic conditions [13][17] Business Line Data and Key Metrics Changes - AWF delivered improved profitability year on year despite a challenging environment [21] - Madison launched a greenfield health channel and secured a place on two key panels within the health sector [22] - Jackson Stone and Wellington were significantly impacted by government spending reductions [23] - Absolute IT was hardest hit nationally but retained key capabilities [23] Market Data and Key Metrics Changes - Unemployment rates reached 5.1% in March, reflecting a 53% increase over two years [25] - The labor market showed signs of strain, with a notable increase in tender activity and preferred supplier contract awards [29] - The contractor book reduced as clients implemented cost control measures [21] Company Strategy and Development Direction - The company is focused on financial sustainability, recovery, and growth, with an emphasis on maintaining operational capacity without compromising service quality [15][18] - Strategic focus on sectors with long-term robustness, including infrastructure, health, and professional services [20] - The company aims to leverage AI and digitization to enhance operational efficiency while maintaining a human touch in recruitment processes [42][43] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the prolonged and challenging trading cycle but expressed optimism about future recovery [14][15] - The company is preparing for better economic conditions, with expectations for FY 2026 to be a year of rebuild and improved financial performance [25][44] - Management emphasized the importance of maintaining strong relationships with clients and focusing on high-value roles [30][32] Other Important Information - The company maintained a strong banking relationship with ASB, with facilities extending to April 2026 [18] - Continuous conversations with ASB are aimed at reducing net debt and improving gearing metrics [19] Q&A Session Summary Question: Concerns about capital and debt levels - A shareholder expressed concerns about the company's capital needs and suggested that more capital is necessary to navigate current challenges [67][68] - Management acknowledged the importance of retaining quality staff and emphasized that the company does not need to be capital intensive [82][84] Question: Impact of AI on service delivery - A shareholder inquired about how AI might fine-tune the company's processes and operations [92] - Management discussed the integration of AI into core operating platforms to enhance efficiency while maintaining a human touch in recruitment [43][96]

Financial Data and Key Metrics Changes - Revenue for FY 2025 was $165.2 million, down 22% from the prior year [17] - Net loss after tax was €2.9 million, an improvement from a €10 million loss in the previous year [17] - Operating expenses were reduced by £6 million through property consolidation and resizing support teams [18] - No dividend was declared for the year ending March 31, 2025, reflecting a prudent approach due to uncertain economic conditions [17][13] Business Line Data and Key Metrics Changes - AWF delivered improved profitability year on year despite a challenging environment, focusing on efficiency and quality business [22] - Madison strengthened its position in mid-senior recruitments and launched a new health channel, securing a place on key panels [22][23] - Jackson Stone and Wellington were significantly impacted by government spending reductions, affecting permanent and contract hires [24] - Absolute IT faced the hardest hit nationally but retained key capabilities [24] Market Data and Key Metrics Changes - Unemployment rates reached 5.1%, a 53% increase over two years, reflecting a seismic shift in the labor market [26] - The labor market participation rate decreased, indicating potential underreporting of unemployment figures [28] - ANZ's business outlook showed a dip in employment intentions, indicating nervousness in hiring across sectors [30] Company Strategy and Development Direction - The company is focusing on high-value roles and longer-term contingent workforce solutions to provide clients with necessary flexibility [32] - There is a strategic emphasis on sectors with greater long-term robustness, such as infrastructure and health [21] - The company aims to leverage its scale as New Zealand's largest recruitment business to capture more opportunities [33] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the prolonged and challenging trading cycle but emphasized a positive leadership approach [15] - The focus remains on financial sustainability, recovery, and growth, with expectations for better performance in FY 2026 and stronger in FY 2027 [26][50] - Management is preparing for an eventual economic rebound, despite current market instability [30][47] Other Important Information - The company is actively working on extending banking facilities with ASB to support growth and reduce interest costs [19] - There is a commitment to maintaining a strong banking relationship and avoiding delinquent debt [19] Q&A Session Summary Question: Concerns about capital requirements and company debt - A shareholder expressed concerns about the company's capital needs and suggested that additional capital could help address current challenges [72][74] - Management acknowledged the importance of retaining quality staff and emphasized that the company does not need to be capital-intensive [86][90] Question: Impact of AI on recruitment processes - A shareholder inquired about how AI might fine-tune recruitment processes and improve operational efficiency [96] - Management discussed ongoing digitization efforts and the integration of AI to enhance recruitment capabilities while maintaining the human touch [45][46]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving agilon health, Inc. and its officers or directors [1] Company Developments - On August 4, 2025, agilon announced the resignation of Steven Sell as President, CEO, and Director of the Board [3] - Following the leadership change, agilon suspended its full-year 2025 financial guidance due to ongoing market uncertainty and the need to optimize operating performance [3] - The stock price of agilon fell by $0.93 per share, a decrease of 51.51%, closing at $0.88 per share on August 5, 2025 [3] Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [4]